FDA Inspection 1229621 — Mary Greeley Medical Center IRB
The FDA completed an inspection of Mary Greeley Medical Center IRB on January 31, 2024 in Ames, IA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 31, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Ames, IA (United States)
Additional Details
IRB